Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU

作者：Annemans Lieven^*; Cleemput Irina; Hulstaert Frank; Simoens Steven

来源：Journal of Comparative Effectiveness Research, 2012, 1(1): 19-29.

DOI：10.2217/CER.11.1

• comparative effectiveness
• EU
• level of innovation
• medical need
• orphan medicines
• personalized medicine
• pharmaceutical innovation

Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.

• 出版日期2012-1